Lista de obras - Jorge Barriuso - Dominio Público Uruguay

18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis

scientific article published on 21 February 2019

A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond

artículo científico publicado en 2014

A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma.

artículo científico

A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer

artículo científico publicado en 2014

A study of the pattern of hospital admissions in a specialist Phase I oncology trials unit: unplanned admissions as an early indicator of patient attrition.

artículo científico publicado en 2010

Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma.

artículo científico publicado en 2008

Aurora kinases as prognostic biomarkers in ovarian carcinoma.

artículo científico publicado en 2009

Biomarker concordance between primary colorectal cancer and its metastases

scientific article published on 04 February 2019

Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience

artículo científico publicado en 2016

Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas

artículo científico publicado en 2019

Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.

artículo científico publicado en 2015

Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?

artículo científico publicado en 2016

Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?

artículo científico publicado en 2009

Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.

artículo científico publicado en 2018

Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas.

artículo científico publicado en 2017

Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response.

artículo científico publicado en 2017

Early adaptation of colorectal cancer cells to the peritoneal cavity is associated with activation of 'stemness' programs and local inflammation

artículo científico publicado en 2020

Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer

scientific article published on 27 November 2019

Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

scientific article published on 31 October 2019

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis

artículo científico publicado en 2015

Follow-Up Recommendations after Curative Resection of Well-Differentiated Neuroendocrine Tumours: Review of Current Evidence and Clinical Practice

artículo científico publicado en 2019

From presentation to paper: Gender disparities in oncological research

artículo científico publicado en 2019

From targeted therapy in ovarian cancer to personalizing therapy for ovarian cancer

scientific article published on 01 May 2011

Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?

artículo científico

Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology ⬇️

artículo científico publicado el 8 de junio de 2013

Hepatocellular carcinoma: Exploring the impact of ethnicity on molecular biology.

artículo científico publicado en 2016

Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy.

artículo científico publicado en 2011

Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study

artículo científico publicado en 2011

Localisation of COX-2 protein is different in breast ductal carcinoma and adjacent non-tumour ductal epithelium.

artículo científico publicado en 2005

MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide

artículo científico publicado en 2015

Molecular characterization of ovarian cancer by gene-expression profiling.

artículo científico publicado en 2010

Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectives.

artículo científico

Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A GEMCAD study

artículo científico publicado en 2013

New Horizons for Precision Medicine in Biliary Tract Cancers

artículo científico publicado en 2017

PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumours

artículo científico publicado en 2018

Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours

scientific article published on 25 January 2019

Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies

artículo científico publicado en 2011

Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignancies

artículo científico publicado en 2011

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

artículo científico publicado en 2012

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study

artículo científico publicado en 2018

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer

artículo científico publicado en 2010

Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial

artículo científico publicado en 2019

Phospholipid hydroperoxide glutathione peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma

artículo científico publicado en 2007

Predicting Response to Standard First-line Treatment in High-grade Serous Ovarian Carcinoma by Angiogenesis-related Genes

artículo científico publicado en 2018

Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study

artículo científico publicado en 2019

Prognostic and predictive biomarkers for somatostatin analogs, peptide receptor radionuclide therapy and serotonin pathway targets in neuroendocrine tumours

artículo científico publicado en 2018

Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy.

artículo científico publicado en 2009

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors

artículo científico publicado en 2016

RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation

artículo científico publicado en 2018

Reply: Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer.

artículo científico publicado en 2010

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)

artículo científico publicado en 2018

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014

artículo científico publicado en 2014

Severe toxicity caused by sorafenib in hepatocellular carcinoma match the data from renal cell carcinoma ⬇️

artículo científico publicado el 31 de enero de 2012

Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational study

artículo científico publicado en 2018

Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes

scientific article published on 08 August 2019

Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)

scientific article published on 21 July 2020

Telotristat ethyl: a new option for the management of carcinoid syndrome.

artículo científico publicado en 2016

Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration

scientific article published on 17 September 2019

The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers

artículo científico publicado en 2018

The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

artículo científico publicado en 2010

The targeted therapy revolution in neuroendocrine tumors: in search of biomarkers for patient selection and response evaluation.

artículo científico publicado en 2013

Tumoural Expression of Connective Tissue Growth Factor (CTGF) Impacts on Survival in Patients Diagnosed with Hepatocellular Carcinoma (HCC).

artículo científico publicado en 2015

Urgent need for consensus: international survey of clinical practice exploring use of platinum-etoposide chemotherapy for advanced extra-pulmonary high grade neuroendocrine carcinoma (EP-G3-NEC)

artículo científico publicado en 2018

Urine telomerase for diagnosis and surveillance of bladder cancer.

artículo científico publicado en 2012

Zebrafish in oncology.

artículo científico publicado en 2015

Zebrafish: a new companion for translational research in oncology.

artículo científico

Lista de obras de Jorge Barriuso

18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis

A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond

A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma.

A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer

A study of the pattern of hospital admissions in a specialist Phase I oncology trials unit: unplanned admissions as an early indicator of patient attrition.

Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma.

Aurora kinases as prognostic biomarkers in ovarian carcinoma.

Biomarker concordance between primary colorectal cancer and its metastases

Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience

Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas

Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.

Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?

Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?

Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.

Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas.

Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response.

Early adaptation of colorectal cancer cells to the peritoneal cavity is associated with activation of 'stemness' programs and local inflammation

Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer

Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis

Follow-Up Recommendations after Curative Resection of Well-Differentiated Neuroendocrine Tumours: Review of Current Evidence and Clinical Practice

From presentation to paper: Gender disparities in oncological research

From targeted therapy in ovarian cancer to personalizing therapy for ovarian cancer

Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?

Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology ⬇️

Hepatocellular carcinoma: Exploring the impact of ethnicity on molecular biology.

Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy.

Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study

Localisation of COX-2 protein is different in breast ductal carcinoma and adjacent non-tumour ductal epithelium.

MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide

Molecular characterization of ovarian cancer by gene-expression profiling.

Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectives.

Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A GEMCAD study

New Horizons for Precision Medicine in Biliary Tract Cancers

PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumours

Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours

Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies

Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignancies

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer

Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial

Phospholipid hydroperoxide glutathione peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma

Predicting Response to Standard First-line Treatment in High-grade Serous Ovarian Carcinoma by Angiogenesis-related Genes

Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study

Prognostic and predictive biomarkers for somatostatin analogs, peptide receptor radionuclide therapy and serotonin pathway targets in neuroendocrine tumours

Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy.

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors

RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation

Reply: Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer.

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014

Severe toxicity caused by sorafenib in hepatocellular carcinoma match the data from renal cell carcinoma ⬇️

Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational study

Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes

Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)

Telotristat ethyl: a new option for the management of carcinoid syndrome.

Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration

The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers

The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

The targeted therapy revolution in neuroendocrine tumors: in search of biomarkers for patient selection and response evaluation.

Tumoural Expression of Connective Tissue Growth Factor (CTGF) Impacts on Survival in Patients Diagnosed with Hepatocellular Carcinoma (HCC).

Urgent need for consensus: international survey of clinical practice exploring use of platinum-etoposide chemotherapy for advanced extra-pulmonary high grade neuroendocrine carcinoma (EP-G3-NEC)

Urine telomerase for diagnosis and surveillance of bladder cancer.

Zebrafish in oncology.

Zebrafish: a new companion for translational research in oncology.